Skip to content
Peptide guide

Peptide bioregulators (Khavinson peptides) explained

Peptide bioregulators are very short peptides, mostly two to four amino acids, from Vladimir Khavinson's Russian aging research, each said to target one organ. The research is mostly Russian cell and animal work, and none is approved in the US or Europe.

This article is educational, not medical advice. Talk with a qualified healthcare professional before using any medicine or peptide.

What are peptide bioregulators?

Peptide bioregulators are very short lab-made peptides, mostly two to four amino acids long, developed by Vladimir Khavinson and colleagues at the Saint Petersburg Institute of Bioregulation and Gerontology. Each one is said to support a specific organ, like the thymus, brain, liver or blood vessels.

The family grew from organ extracts used in the Soviet Union, like thymalin from the thymus.

Peptide bioregulators compared

Bioregulator Sequence or type Organ it is said to target Evidence
Epitalon Ala-Glu-Asp-Gly Pineal gland, aging Cell and animal studies; small Russian human studies
Thymalin Thymus peptide mixture Immune system Used as a medicine in Russia; small Russian studies
Pinealon Glu-Asp-Arg Brain Cell and animal studies
Vilon Lys-Glu Thymus, immune system Cell and animal studies
Vesugen Lys-Glu-Asp Blood vessels Cell studies
Livagen Lys-Glu-Asp-Ala Liver Cell studies
Bronchogen Ala-Glu-Asp-Leu Lungs and airways Cell studies
Cortagen Short synthetic peptide Brain cortex Animal studies
Endoluten Marketed pineal bioregulator product Pineal gland No peer-reviewed human trials found

How are peptide bioregulators supposed to work?

Their developers propose that these tiny peptides get inside cells, even into the nucleus, and change which genes are active in a particular tissue. In this view, each peptide restores the normal function of an aging organ.

This is unlike most medicines, which act on receptors on the cell surface. The gene-switching idea comes almost entirely from the same research group and hasn’t been confirmed by independent labs.

What does the research on bioregulators show?

Most of the evidence is cell and animal research from a small number of Russian groups. The longest human studies involve thymalin and epitalon in elderly people in Saint Petersburg, which reported better immune markers and lower death rates, but they were small and haven’t been repeated elsewhere.

For Vilon, Vesugen, Livagen, Bronchogen and Cortagen, there are no rigorous human trials. Endoluten is sold as a product rather than studied as a defined compound in peer-reviewed trials.

Are peptide bioregulators safe?

Their safety in people hasn’t been properly tested. Few side effects are reported, but small studies can miss problems, and products sold online, often as capsules, aren’t checked for purity or content.

None is approved as a medicine by the FDA or the European Medicines Agency. Thymalin is used as a medicine in Russia, and some others are sold there and online as supplement-style capsules.

Peptides in this article

  • Epitalon: Research peptide: not approved for human use
  • Thymalin: Used as a medicine in Russia; not FDA-approved
  • Pinealon: Research peptide: cell and animal studies; not approved

Frequently asked questions

Do peptide bioregulators work?

There is no rigorous independent evidence that they do. Most studies come from one Russian research group and haven't been repeated elsewhere.

Are peptide bioregulators legal?

They aren't approved as medicines in the US or Europe. Some are sold online as capsules marketed like supplements, which doesn't make them proven or approved.

How are bioregulators supposed to work?

Their developers propose that very short peptides enter cells and influence which genes are switched on in a specific organ. That idea hasn't been confirmed independently.

Sources

  1. Empire Medical Training, Peptide bioregulators: Khavinson peptides and what the evidence shows
  2. Wikipedia, Vladimir Khavinson
  3. Wikipedia, Pinealon (with cited studies)
  4. Overview of Epitalon: Highly Bioactive Pineal Tetrapeptide with Promising Properties (2025)

Last updated .

More peptide articles